ArcticZymes Technologies Logo

ArcticZymes Technologies

Develops novel enzymes from Arctic organisms for diagnostics, therapeutics, and biopharma.

AZT | BR

Overview

Corporate Details

ISIN(s):
NO0010014632
LEI:
5967007LIEEXZXGR7K47
Country:
Norway
Address:
FORSKNINGSPARKEN, 9019 TROMSØ
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

ArcticZymes Technologies is a life sciences company specializing in the development, manufacturing, and sale of novel recombinant enzymes. With over 30 years of focused expertise, the company develops unique, high-performance enzymes, often derived from Arctic marine organisms, that are engineered to function in challenging conditions such as high-salt and low-temperature environments. Its products are critical components for customers in the molecular research, diagnostics (MDx), therapeutics, and biopharmaceutical manufacturing sectors, with key applications in gene therapy, vaccine production, and DNA purification. The company provides customized enzymatic solutions through close collaboration with its clients to advance molecular science.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-11-28 17:03
Regulatory News Service
ArcticZymes Technologies Completes Share Buyback to Support Employee Share Purc…
English 67.0 KB
2025-11-28 17:03
Transaction in Own Shares
ArcticZymes Technologies Completes Share Buyback to Support Employee Share Purc…
English 98.6 KB
2025-11-28 17:03
Transaction in Own Shares
ArcticZymes Technologies Completes Share Buyback to Support Employee Share Purc…
English 2.4 KB
2025-11-10 22:00
Director's Dealing
Long-Term Incentive Plan - grant of share options to primary insiders - Attachm…
English 1.5 MB
2025-11-10 22:00
Remuneration Information
Long-Term Incentive Plan - grant of share options to primary insiders
English 2.3 KB
2025-11-06 07:00
Earnings Release
ArcticZymes Technologies Reports Q3 2025 Results: Continued Growth Momentum and…
English 272.3 KB
2025-11-06 07:00
Quarterly Report
ArcticZymes Technologies Reports Q3 2025 Results: Continued Growth Momentum and…
English 1.7 MB
2025-11-06 07:00
Investor Presentation
ArcticZymes Technologies Reports Q3 2025 Results: Continued Growth Momentum and…
English 2.9 MB
2025-11-06 07:00
Earnings Release
ArcticZymes Technologies Reports Q3 2025 Results: Continued Growth Momentum and…
English 6.5 KB
2025-10-30 13:46
Report Publication Announcement
ArcticZymes Technologies ASA: Invitation to presentation of Q3 and 9M 2025 resu…
English 1.1 KB
2025-10-29 08:00
Regulatory News Service
ArcticZymes ASA Appoints New Exclusive European Distributor for its Bioprocess …
English 184.8 KB
2025-10-29 08:00
Regulatory News Service
ArcticZymes ASA Appoints New Exclusive European Distributor for its Bioprocess …
English 4.8 KB
2025-09-16 10:00
Investor Presentation
ArcticZymes Technologies to present at the Pareto Securities 16th Healthcare Co…
English 2.8 MB
2025-09-16 10:00
Investor Presentation
ArcticZymes Technologies presenterer på Pareto Securities 16 Healthcare Confere…
English 2.8 MB
2025-09-16 10:00
Report Publication Announcement
ArcticZymes Technologies to present at the Pareto Securities 16th Healthcare Co…
English 776 bytes

Automate Your Workflow. Get a real-time feed of all ArcticZymes Technologies filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for ArcticZymes Technologies

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for ArcticZymes Technologies via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Edesa Biotech, Inc. Logo
Develops treatments for inflammatory and immune diseases like Acute Respiratory Distress Syndrome.
United States of America
EDSA
Edgewise Therapeutics, Inc. Logo
Developing novel therapeutics for rare and serious muscle disorders.
United States of America
EWTX
Editas Medicine, Inc. Logo
Developing CRISPR-based genomic medicines to treat serious and rare genetic diseases.
United States of America
EDIT
Eevia Health Plc Logo
Manufactures validated polyphenol extracts from Arctic plants for the supplement & food industries.
Finland
EEVIA
Egetis Therapeutics Logo
Develops and commercializes drugs for serious rare diseases with unmet medical needs.
Sweden
EGTX
EIKEN CHEMICAL CO.,LTD. Logo
Manufacturer of clinical diagnostics, specializing in FIT systems for cancer and microbiological tests.
Japan
4549
Eisai Co., Ltd. Logo
A global, research-based pharmaceutical firm that develops and markets prescription and OTC drugs.
Japan
4523
Elanco Animal Health Inc Logo
Develops medicines, vaccines, and services to treat and prevent disease in pets and farm animals.
United States of America
ELAN
Eledon Pharmaceuticals, Inc. Logo
Develops immunomodulatory therapies to prevent organ rejection in transplant patients.
United States of America
ELDN
Elicera Therapeutics AB Logo
Develops CAR T-cell & oncolytic virus therapies for cancer, enhanced by its iTANK platform.
Sweden
ELIC

Talk to a Data Expert

Have a question? We'll get back to you promptly.